Latest Industry Insights
Industry Insight
ctDNA, CTCs and the Future of Liquid Biopsy
Discover insights on the challenges of CTCs and ctDNA from liquid biopsies as cancer diagnostic tools, how novel technology is helping to overcome some of these issues and the future monitoring landscape.
Industry Insight
Molecular Glues Meet Precision Discovery To Advance Oncology Treatments
From theory to clinic, explore how molecular glue innovation is transforming targeted protein degradation for cancer and other diseases. Offering a new path to degrade targets once thought undruggable.
Industry Insight
Building Agility, Compliance and Sustainability in Sample Storage
In this interview, discover how Astoriom's Integrated Stability & Sustainability Outsourcing Model addresses traditional storage challenges and enables biopharma companies to respond more nimbly to disruptions.
Industry Insight
Building Trust in Cancer AI Starts With Better Data
In this conversation, Joe Day speaks about the most exciting developments in AI-powered cancer research, the critical importance of diverse, high-quality data and what it takes to build patient trust.
Industry Insight
Making Single-Cell Functional Analysis Accessible to All
Today, single-cell technologies are not only dissecting genomic, transcriptomic and proteomic profiles but also enabling dynamic measurements of cellular functions. Bruker's new Beacon Discovery Platform could make this a reality for more labs.
Industry Insight
How At-Home Testing Is Changing Cervical Cancer Screening
In this interview, Technology Networks spoke with Kara Egan, CEO and co-founder of Teal Health, to learn more about how they are reshaping cervical cancer prevention.
Industry Insight
Funding Will Advance Third-Party Verified Sustainability in Science
James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.
Industry Insight
How Astrophysics Is Powering Cancer Innovation
Technology Networks spoke with Dr. Irina Babina, chief executive officer of Concr, to explore the origins of the company, the science behind its platform and the tangible impact it hopes to deliver for patients and healthcare systems alike.
Industry Insight
Bacteria-Based Technology Could Revolutionize Solid Tumor Treatment
At the BioTrinity 2025 conference, Technology Networks spoke with Dr. Pedro Correa de Sampaio, co-founder and CEO of Neobe, who are utilizing synthetic biology to engineer bacteria capable of breaking down the barriers within tumors.
Industry Insight
How Radiopharmaceuticals Are Revolutionizing Cancer Therapy
In this article, Technology Networks spoke with Dr. Jack Hoppin and Dr. John Babich from Ratio Therapeutics to learn more about the recent radiopharmaceutical revolution.
Advertisement
